nach oben

European Journal of Nutrition

Erschienen in:

19.05.2022 | Original Contribution

Associations of baseline use of fish oil with progression of cardiometabolic multimorbidity and mortality among patients with hypertension: a prospective study of UK Biobank

verfasst von: Tianqi Ma, Lingfang He, Yi Luo, Jinchen Li, Guogang Zhang, Xunjie Cheng, Yongping Bai

Erschienen in: European Journal of Nutrition | Ausgabe 7/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The role of fish oil in the prognosis of hypertensive patients is unknown. This study investigated the associations of fish oil supplementation with the progression of cardiometabolic multimorbidity (CMM) and mortality among patients with hypertension.

Methods

Based on UK Biobank, we enrolled participants with hypertension and free of other cardiometabolic diseases. The exposure was baseline use of fish oil derived from questionnaires at baseline. The primary outcomes were the incidence of CMM and all-cause mortality. Competing risk models and flexible parametric proportion-hazards models were fitted to assess the adjusted hazard ratios (HRs) for the risk of CMM and mortality outcomes, respectively.

Results

Among 81,579 participants involved [50.37%, men; mean age, 59.38 years (standard deviation, 7.23 years)], 15,990 CMM events and 6456 all-cause deaths were reported (median follow-up, 12.23 years). In multivariable-adjusted models, baseline use of fish oil was associated with 8% lower risk of CMM [95% confidence interval (95% CI) 0.89–0.96, P < 0.001] and 10% lower risk of all-cause mortality (95% CI 0.85–0.95, P < 0.001).

Conclusion

In individuals with hypertension, baseline use of fish oil was associated with a reduced risk of CMM and all-cause mortality, and further clinical trials are needed to prove this hypothesis.

Nur mit Berechtigung zugänglich

Partridge L, Deelen J, Slagboom PE (2018) Facing up to the global challenges of ageing. Nature 561(7721):45–56. https://doi.org/10.1038/s41586-018-0457-8CrossRefPubMed

Smith SM, Soubhi H, Fortin M, Hudon C, O’Dowd T (2012) Managing patients with multimorbidity: systematic review of interventions in primary care and community settings. BMJ 345:e5205. https://doi.org/10.1136/bmj.e5205CrossRefPubMedPubMedCentral

Glynn LG (2009) Multimorbidity: another key issue for cardiovascular medicine. Lancet 374(9699):1421–1422. https://doi.org/10.1016/S0140-6736(09)61863-8CrossRefPubMed

Emerging Risk Factors C, Di Angelantonio E, Kaptoge S, Wormser D, Willeit P, Butterworth AS, Bansal N, O’Keeffe LM, Gao P, Wood AM, Burgess S, Freitag DF, Pennells L, Peters SA, Hart CL, Haheim LL, Gillum RF, Nordestgaard BG, Psaty BM, Yeap BB, Knuiman MW, Nietert PJ, Kauhanen J, Salonen JT, Kuller LH, Simons LA, van der Schouw YT, Barrett-Connor E, Selmer R, Crespo CJ, Rodriguez B, Verschuren WM, Salomaa V, Svardsudd K, van der Harst P, Bjorkelund C, Wilhelmsen L, Wallace RB, Brenner H, Amouyel P, Barr EL, Iso H, Onat A, Trevisan M, D’Agostino RB Sr, Cooper C, Kavousi M, Welin L, Roussel R, Hu FB, Sato S, Davidson KW, Howard BV, Leening MJ, Leening M, Rosengren A, Dorr M, Deeg DJ, Kiechl S, Stehouwer CD, Nissinen A, Giampaoli S, Donfrancesco C, Kromhout D, Price JF, Peters A, Meade TW, Casiglia E, Lawlor DA, Gallacher J, Nagel D, Franco OH, Assmann G, Dagenais GR, Jukema JW, Sundstrom J, Woodward M, Brunner EJ, Khaw KT, Wareham NJ, Whitsel EA, Njolstad I, Hedblad B, Wassertheil-Smoller S, Engstrom G, Rosamond WD, Selvin E, Sattar N, Thompson SG, Danesh J (2015) Association of cardiometabolic multimorbidity with mortality. JAMA 314(1):52–60. https://doi.org/10.1001/jama.2015.7008CrossRef

Zhang D, Tang X, Shen P, Si Y, Liu X, Xu Z, Wu J, Zhang J, Lu P, Lin H, Gao P (2019) Multimorbidity of cardiometabolic diseases: prevalence and risk for mortality from one million Chinese adults in a longitudinal cohort study. BMJ Open 9(3):e024476. https://doi.org/10.1136/bmjopen-2018-024476CrossRefPubMedPubMedCentral

Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A (2006) Blood pressure and the global burden of disease 2000 Part II estimates of attributable burden. J Hypertens 24(3):423–430. https://doi.org/10.1097/01.hjh.0000209973.67746.f0CrossRefPubMed

Lackland DT, Weber MA (2015) Global burden of cardiovascular disease and stroke: hypertension at the core. Can J Cardiol 31(5):569–571. https://doi.org/10.1016/j.cjca.2015.01.009CrossRefPubMed

Chudasama YV, Khunti KK, Zaccardi F, Rowlands AV, Yates T, Gillies CL, Davies MJ, Dhalwani NN (2019) Physical activity, multimorbidity, and life expectancy: a UK Biobank longitudinal study. BMC Med 17(1):108. https://doi.org/10.1186/s12916-019-1339-0CrossRefPubMedPubMedCentral

Freisling H, Viallon V, Lennon H, Bagnardi V, Ricci C, Butterworth AS, Sweeting M, Muller D, Romieu I, Bazelle P, Kvaskoff M, Arveux P, Severi G, Bamia C, Kuhn T, Kaaks R, Bergmann M, Boeing H, Tjonneland A, Olsen A, Overvad K, Dahm CC, Menendez V, Agudo A, Sanchez MJ, Amiano P, Santiuste C, Gurrea AB, Tong TYN, Schmidt JA, Tzoulaki I, Tsilidis KK, Ward H, Palli D, Agnoli C, Tumino R, Ricceri F, Panico S, Picavet HSJ, Bakker M, Monninkhof E, Nilsson P, Manjer J, Rolandsson O, Thysell E, Weiderpass E, Jenab M, Riboli E, Vineis P, Danesh J, Wareham NJ, Gunter MJ, Ferrari P (2020) Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. BMC Med 18(1):5. https://doi.org/10.1186/s12916-019-1474-7CrossRefPubMedPubMedCentral

10.

Singh-Manoux A, Fayosse A, Sabia S, Tabak A, Shipley M, Dugravot A, Kivimaki M (2018) Clinical, socioeconomic, and behavioural factors at age 50 years and risk of cardiometabolic multimorbidity and mortality: A cohort study. PLoS Med 15(5):e1002571. https://doi.org/10.1371/journal.pmed.1002571CrossRefPubMedPubMedCentral

11.

Wikstrom K, Lindstrom J, Harald K, Peltonen M, Laatikainen T (2015) Clinical and lifestyle-related risk factors for incident multimorbidity: 10-year follow-up of Finnish population-based cohorts 1982–2012. Eur J Intern Med 26(3):211–216. https://doi.org/10.1016/j.ejim.2015.02.012CrossRefPubMed

12.

Chudasama YV, Zaccardi F, Gillies CL, Dhalwani NN, Yates T, Rowlands AV, Davies MJ, Khunti K (2020) Leisure-time physical activity and life expectancy in people with cardiometabolic multimorbidity and depression. J Intern Med 287(1):87–99. https://doi.org/10.1111/joim.12987CrossRefPubMed

13.

Calder PC (2018) Very long-chain n-3 fatty acids and human health: fact, fiction and the future. Proc Nutr Soc 77(1):52–72. https://doi.org/10.1017/S0029665117003950CrossRefPubMed

14.

Tummala R, Ghosh RK, Jain V, Devanabanda AR, Bandyopadhyay D, Deedwania P, Aronow WS (2019) Fish oil and cardiometabolic diseases: recent updates and controversies. Am J Med 132(10):1153–1159. https://doi.org/10.1016/j.amjmed.2019.04.027CrossRefPubMed

15.

Innes JK, Calder PC (2020) Marine omega-3 (N-3) fatty acids for cardiovascular health: an update for 2020. Int J Mol Sci. https://doi.org/10.3390/ijms21041362CrossRefPubMedPubMedCentral

16.

Agbabiaka TB, Spencer NH, Khanom S, Goodman C (2018) Prevalence of drug-herb and drug-supplement interactions in older adults: a cross-sectional survey. Br J Gen Pract 68(675):e711–e717. https://doi.org/10.3399/bjgp18X699101CrossRefPubMedPubMedCentral

17.

Savikko N, Pitkala KH, Laurila JV, Suominen MH, Tilvis RS, Kautiainen H, Strandberg TE (2014) Secular trends in the use of vitamins, minerals and fish-oil products in two cohorts of community-dwelling older people in Helsinki–population-based surveys in 1999 and 2009. J Nutr Health Aging 18(2):150–154. https://doi.org/10.1007/s12603-013-0381-4CrossRefPubMed

18.

Kantor ED, Rehm CD, Du M, White E, Giovannucci EL (2016) Trends in dietary supplement use among US adults from 1999–2012. JAMA 316(14):1464–1474. https://doi.org/10.1001/jama.2016.14403CrossRefPubMedPubMedCentral

19.

Zhang Y, Zhuang P, He W, Chen JN, Wang WQ, Freedman ND, Abnet CC, Wang JB, Jiao JJ (2018) Association of fish and long-chain omega-3 fatty acids intakes with total and cause-specific mortality: prospective analysis of 421 309 individuals. J Intern Med 284(4):399–417. https://doi.org/10.1111/joim.12786CrossRefPubMed

20.

Li ZH, Zhong WF, Liu S, Kraus VB, Zhang YJ, Gao X, Lv YB, Shen D, Zhang XR, Zhang PD, Huang QM, Chen Q, Wu XB, Shi XM, Wang D, Mao C (2020) Associations of habitual fish oil supplementation with cardiovascular outcomes and all cause mortality: evidence from a large population based cohort study. BMJ 368:m456. https://doi.org/10.1136/bmj.m456CrossRefPubMedPubMedCentral

21.

Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, Gibson H, Albert CM, Gordon D, Copeland T, D’Agostino D, Friedenberg G, Ridge C, Bubes V, Giovannucci EL, Willett WC, Buring JE (2019) Marine n-3 fatty acids and prevention of cardiovascular disease and cancer. N Engl J Med 380(1):23–32. https://doi.org/10.1056/NEJMoa1811403CrossRefPubMed

22.

Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM, Investigators R-I (2019) Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med 380(1):11–22. https://doi.org/10.1056/NEJMoa1812792CrossRefPubMed

23.

Nicholls SJ, Lincoff AM, Garcia M, Bash D, Ballantyne CM, Barter PJ, Davidson MH, Kastelein JJP, Koenig W, McGuire DK, Mozaffarian D, Ridker PM, Ray KK, Katona BG, Himmelmann A, Loss LE, Rensfeldt M, Lundstrom T, Agrawal R, Menon V, Wolski K, Nissen SE (2020) Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH Randomized Clinical Trial. JAMA 324(22):2268–2280. https://doi.org/10.1001/jama.2020.22258CrossRefPubMedPubMedCentral

24.

Miller PE, Van Elswyk M, Alexander DD (2014) Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials. Am J Hypertens 27(7):885–896. https://doi.org/10.1093/ajh/hpu024CrossRefPubMedPubMedCentral

25.

Campbell F, Dickinson HO, Critchley JA, Ford GA, Bradburn M (2013) A systematic review of fish-oil supplements for the prevention and treatment of hypertension. Eur J Prev Cardiol 20(1):107–120. https://doi.org/10.1177/2047487312437056CrossRefPubMed

26.

Yang B, Shi MQ, Li ZH, Shi L, Wang AM, Guo XJ, Li D (2019) Effects of n-3 fatty acid supplements on cardiometabolic profiles in hypertensive patients with abdominal obesity in Inner Mongolia: a randomized controlled trial. Food Funct 10(3):1661–1670. https://doi.org/10.1039/c8fo01707gCrossRefPubMed

27.

Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M, Liu B, Matthews P, Ong G, Pell J, Silman A, Young A, Sprosen T, Peakman T, Collins R (2015) UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 12(3):e1001779. https://doi.org/10.1371/journal.pmed.1001779CrossRefPubMedPubMedCentral

28.

Palmer LJ (2007) UK Biobank: bank on it. Lancet 369(9578):1980–1982. https://doi.org/10.1016/S0140-6736(07)60924-6CrossRefPubMed

29.

Learn-more-about-uk-biobank. https://www.ukbiobank.ac.uk/learn-more-about-uk-biobank/about-us.

30.

Tyrrell J, Jones SE, Beaumont R, Astley CM, Lovell R, Yaghootkar H, Tuke M, Ruth KS, Freathy RM, Hirschhorn JN, Wood AR, Murray A, Weedon MN, Frayling TM (2016) Height, body mass index, and socioeconomic status: mendelian randomisation study in UK Biobank. BMJ 352:i582. https://doi.org/10.1136/bmj.i582CrossRefPubMedPubMedCentral

31.

Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P (2017) Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation 135(10):e146–e603. https://doi.org/10.1161/CIR.0000000000000485CrossRefPubMedPubMedCentral

32.

Cassidy S, Chau JY, Catt M, Bauman A, Trenell MI (2016) Cross-sectional study of diet, physical activity, television viewing and sleep duration in 233,110 adults from the UK Biobank; the behavioural phenotype of cardiovascular disease and type 2 diabetes. BMJ Open 6(3):e010038. https://doi.org/10.1136/bmjopen-2015-010038CrossRefPubMedPubMedCentral

33.

Lambert PC, Royston P (2009) Further development of flexible parametric models for survival analysis. Stata J 9(2):265–290. https://doi.org/10.1177/1536867x0900900206CrossRef

34.

Liu X, Zhuang P, Li Y, Wu F, Wan X, Zhang Y, Jiao J (2022) Association of fish oil supplementation with risk of incident dementia: a prospective study of 215,083 older adults. Clin Nutr 41(3):589–598. https://doi.org/10.1016/j.clnu.2022.01.002CrossRefPubMed

35.

Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ (2002) Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 20(8):1493–1499. https://doi.org/10.1097/00004872-200208000-00010CrossRefPubMed

36.

Yang B, Shi L, Wang AM, Shi MQ, Li ZH, Zhao F, Guo XJ, Li D (2019) Lowering effects of n-3 fatty acid supplements on blood pressure by reducing plasma angiotensin II in inner mongolia hypertensive patients: a double-blind randomized controlled trial. J Agric Food Chem 67(1):184–192. https://doi.org/10.1021/acs.jafc.8b05463CrossRefPubMed

37.

Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies C (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360(9349):1903–1913. https://doi.org/10.1016/s0140-6736(02)11911-8CrossRefPubMed

38.

Mills KT, Stefanescu A, He J (2020) The global epidemiology of hypertension. Nat Rev Nephrol 16(4):223–237. https://doi.org/10.1038/s41581-019-0244-2CrossRefPubMedPubMedCentral

39.

Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, White IR, Caulfield MJ, Deanfield JE, Smeeth L, Williams B, Hingorani A, Hemingway H (2014) Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet 383(9932):1899–1911. https://doi.org/10.1016/S0140-6736(14)60685-1CrossRefPubMedPubMedCentral

40.

Ferrannini E, Cushman WC (2012) Diabetes and hypertension: the bad companions. Lancet 380(9841):601–610. https://doi.org/10.1016/S0140-6736(12)60987-8CrossRefPubMed

41.

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (1999). Lancet 354 (9177):447–455

42.

Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM (1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2(8666):757–761. https://doi.org/10.1016/s0140-6736(89)90828-3CrossRefPubMed

43.

Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K, Japan EPAlisI, (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369(9567):1090–1098. https://doi.org/10.1016/S0140-6736(07)60527-3CrossRefPubMed

44.

Hu Y, Hu FB, Manson JE (2019) Marine omega-3 supplementation and cardiovascular disease: an updated meta-analysis of 13 randomized controlled trials involving 127 477 participants. J Am Heart Assoc 8(19):e013543. https://doi.org/10.1161/JAHA.119.013543CrossRefPubMedPubMedCentral

45.

Chen GC, Arthur R, Qin LQ, Chen LH, Mei Z, Zheng Y, Li Y, Wang T, Rohan TE, Qi Q (2021) Association of oily and nonoily fish consumption and fish oil supplements with incident type 2 diabetes: a large population-based prospective study. Diabetes Care 44(3):672–680. https://doi.org/10.2337/dc20-2328CrossRefPubMedPubMedCentral

46.

Gao H, Geng T, Huang T, Zhao Q (2017) Fish oil supplementation and insulin sensitivity: a systematic review and meta-analysis. Lipids Health Dis 16(1):131. https://doi.org/10.1186/s12944-017-0528-0CrossRefPubMedPubMedCentral

47.

O’Mahoney LL, Matu J, Price OJ, Birch KM, Ajjan RA, Farrar D, Tapp R, West DJ, Deighton K, Campbell MD (2018) Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials. Cardiovasc Diabetol 17(1):98. https://doi.org/10.1186/s12933-018-0740-xCrossRefPubMedPubMedCentral

48.

Gonzalez-Periz A, Horrillo R, Ferre N, Gronert K, Dong B, Moran-Salvador E, Titos E, Martinez-Clemente M, Lopez-Parra M, Arroyo V, Claria J (2009) Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J 23(6):1946–1957. https://doi.org/10.1096/fj.08-125674CrossRefPubMedPubMedCentral

49.

Siscovick DS, Barringer TA, Fretts AM, Wu JH, Lichtenstein AH, Costello RB, Kris-Etherton PM, Jacobson TA, Engler MB, Alger HM, Appel LJ, Mozaffarian D, American Heart Association Nutrition Committee of the Council on L, Cardiometabolic H, Council on E, Prevention, Council on Cardiovascular Disease in the Y, Council on C, Stroke N, Council on Clinical C (2017) Omega-3 polyunsaturated fatty acid (Fish Oil) supplementation and the prevention of clinical cardiovascular disease: a science advisory from the American Heart Association. Circulation 135(15):e867–e884. https://doi.org/10.1161/CIR.0000000000000482CrossRefPubMedPubMedCentral

50.

Ueno Y, Miyamoto N, Yamashiro K, Tanaka R, Hattori N (2019) Omega-3 polyunsaturated fatty acids and stroke burden. Int J Mol Sci. https://doi.org/10.3390/ijms20225549CrossRefPubMedPubMedCentral

51.

Leon H, Shibata MC, Sivakumaran S, Dorgan M, Chatterley T, Tsuyuki RT (2008) Effect of fish oil on arrhythmias and mortality: systematic review. BMJ 337:a2931. https://doi.org/10.1136/bmj.a2931CrossRefPubMedPubMedCentral

52.

Budoff MJ, Bhatt DL, Kinninger A, Lakshmanan S, Muhlestein JB, Le VT, May HT, Shaikh K, Shekar C, Roy SK, Tayek J, Nelson JR (2020) Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial. Eur Heart J 41(40):3925–3932. https://doi.org/10.1093/eurheartj/ehaa652CrossRefPubMedPubMedCentral

53.

Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O (2020) 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 41(1):111–188. https://doi.org/10.1093/eurheartj/ehz455CrossRefPubMed

54.

Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, Collins R, Allen NE (2017) Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am J Epidemiol 186(9):1026–1034. https://doi.org/10.1093/aje/kwx246CrossRefPubMedPubMedCentral

Titel: Associations of baseline use of fish oil with progression of cardiometabolic multimorbidity and mortality among patients with hypertension: a prospective study of UK Biobank
verfasst von: Tianqi Ma
Lingfang He
Yi Luo
Jinchen Li
Guogang Zhang
Xunjie Cheng
Yongping Bai
Publikationsdatum: 19.05.2022
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nutrition / Ausgabe 7/2022
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-022-02889-w

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Associations of baseline use of fish oil with progression of cardiometabolic multimorbidity and mortality among patients with hypertension: a prospective study of UK Biobank

Abstract

Purpose

Methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2022

Maternal and infant probiotic administration for morbidity of very low birth weight infants: a three-arm randomized placebo-controlled trial

Dietary score associations with markers of chronic low-grade inflammation: a cross-sectional comparative analysis of a middle- to older-aged population

Individually tailored nutritional guidance improved dietary intake of older family caregivers: a randomized controlled trial

Hydration and meal habits of physicians and medical learners: a literature review

The inflammatory potential of the diet in childhood is associated with cardiometabolic risk in adolescence/young adulthood in the ALSPAC birth cohort

The FADS1 genotypes modify the effect of linoleic acid-enriched diet on adipose tissue inflammation via pro-inflammatory eicosanoid metabolism

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin